Clinical Hemorheology and Microcirculation - Volume 40, issue 1
Purchase individual online access for 1 year to this journal.
Price: EUR 185.00
Impact Factor 2021: 2.375
Clinical Hemorheology and Microcirculation, a peer-reviewed international scientific journal, serves as an aid to understanding the flow properties of blood and the relationship to normal and abnormal physiology. The rapidly expanding science of hemorheology concerns blood, its components and the blood vessels with which blood interacts. It includes perihemorheology, i.e., the rheology of fluid and structures in the perivascular and interstitial spaces as well as the lymphatic system. The clinical aspects include pathogenesis, symptomatology and diagnostic methods, and the fields of prophylaxis and therapy in all branches of medicine and surgery, pharmacology and drug research.
The endeavour of the Editors-in-Chief and publishers of
Clinical Hemorheology and Microcirculation is to bring together contributions from those working in various fields related to blood flow all over the world. The editors of
Clinical Hemorheology and Microcirculation are from those countries in Europe, Asia, Australia and America where appreciable work in clinical hemorheology and microcirculation is being carried out. Each editor takes responsibility to decide on the acceptance of a manuscript. He is required to have the manuscript appraised by two referees and may be one of them himself. The executive editorial office, to which the manuscripts have been submitted, is responsible for rapid handling of the reviewing process.
Clinical Hemorheology and Microcirculation accepts original papers, brief communications, mini-reports and letters to the Editors-in-Chief. Review articles, providing general views and new insights into related subjects, are regularly invited by the Editors-in-Chief. Proceedings of international and national conferences on clinical hemorheology (in original form or as abstracts) complete the range of editorial features.
The following professionals and institutions will benefit most from subscribing to
Clinical Hemorheology and Microcirculation: medical practitioners in all fields including hematology, cardiology, geriatrics, angiology, surgery, obstetrics and gynecology, ophthalmology, otology, and neurology. Pharmacologists, clinical laboratories, blood transfusion centres, manufacturing firms producing diagnostic instruments, and the pharmaceutical industry will also benefit.
Important new topics will increasingly claim more pages of
Clinical Hemorheology and Microcirculation: the role of hemorheological and microcirculatory disturbances for epidemiology and prognosis, in particular regarding cardiovascular disorders, as well as its significance in the field of geriatrics. Authors and readers are invited to contact the editors for specific information or to make suggestions.
Abstract: In vitro experiments to investigate the hematocrit effect on human blood flow in microcirculation were carried out using a micro-PIV technique. The micro-PIV system consisted of a 2 head Nd:YAG laser as a illumination light, a cooled CCD camera, a delay generator and a personal computer for control and data processing. Human blood with a hematocrit of 20, 30 and 40% was supplied into a microtube of 100 μm in diameter using a syringe pump. Fluorescent particles of 1.0 μm in mean diameter were seeded in the blood flow as tracers to measure instantaneous velocity fields by applying a cross-correlation…PIV algorithm. The mean velocity field information was obtained by ensemble averaging the instantaneous velocity field data obtained. The hemorheological characteristics related with the blood flow in the microtube were also evaluated as functions of flow rate and hematocrit using the PIV data. The blood flow has a cell-free layer near the tube wall and this layer's thickness is increased with the increasing flow speed due to the radial migration. As the hematocrit increases, the velocity profile starts acquiring non-Newtonian features under low flow rate conditions. The hemorheolgical characteristics were found to influence largely on the viscosity and shear rate of blood flow.
Abstract: In a group of young subjects with acute myocardial infarction (AMI) (68 men and 7 women; mean age 39.6±5.7 years) we examined the plasma concentration of elastase, the thiobarbituric acid-reactive substances (TBARS) and the total antioxidant status (TAS) at the initial stage of AMI. In this group we found an increase of elastase (p<0.001) and TBARS (p<0.001) and a decrease of TAS (p<0.001). A statistical correlation was observed in the whole group of AMI patients between plasma elastase and TAS (p<0.01) and this correlation was more statistically significant in patients with more risk factors and not in those with more…involved vessels.
Keywords: Juvenile myocardial infarction, plasma elastase, total antioxidant status
Abstract: In this study we present a three-dimensional angiogenesis assay in vitro that allows the evaluation of the influence of Poly(lactic-co-glycolic acid) based implants seeded with VEGF-A165 stimulated/activated human CD14+ monocytes on the attraction and migration of human micro vascular endothelial cells (HMVEC-L). Primary HMEC of the capillary bed were cultured on an extracellular matrix generated by bovine corneal endothelial cells (BCEC). The HMEC layer was covered by an agarose gel, upon which a Poly(lactic-co-glycolic acid)/CaP polymer with a Calcium-Phosphate (CaP) nanostructured surface was placed. This scaffold has already been shown to interact with endothelial cells and endothelial progenitor cells respectively…in vivo. It was seeded with angiogenically stimulated (VEGF-A165) human CD14+ monocytes, to get a monocyte/macrophage fraction, which can promote angiogenesis, tissue remodelling and tissue repair due to the secretion of growth factors, cytokines, chemokines and enzymes. The study demonstrated that this assay is suitable to test angiogenic effects by stimulated human CD14+ monocytes on human microvascular endothelial cells influenced by Poly(lactic-co-glycolic acid)/CaP scaffolds with a nanostructured CaP surface. The assay can exclude effects on migration caused by gravity and also allows testing in a physiological environment on an extracellular matrix secreted by endothelial cells.
Abstract: The article considers new and potential uses for contrast-enhanced ultrasound (CEUS) in radiology. CEUS could become an early, sensitive and inexpensive tool for managing tumor ablation in patients in whom microvascular imaging adds diagnostic information, especially in inflammatory diseases. Its sensitivity in detecting focal liver lesions is comparable to that of other imaging modalities such as computed tomography or magnetic resonance imaging, and it provides a high accuracy in lesion characterization. The main indications in renal diseases are characterization of complicated cysts, arterial infarction and masses in the collecting system and renal vein. As local ablation therapy gains clinical acceptance…in liver and recently in renal tumors, CEUS may play an important role in planning the procedure, needle navigation and the follow-up of these patients. In rheumatology, monitoring and optimizing the effectiveness of therapy may also become an important task for CEUS. In breast and prostate cancers, CEUS can add diagnostic value, especially in early detection of tumor recurrence. In lung disease, the technique has considerable potential for characterizing non-ventilated tissues and helping with interventional procedures. In vascular disease, CEUS is of value in arterial stenosis, but its greatest benefit may be in characterizing changes within the vessel wall. It also greatly increases the success rate of transcranial examinations. CEUS is expected to play a major role in detecting sentinel lymph nodes and estimating the tumor burden of involved lymphatic tissue. The possible indications and potential benefits of CEUS are numerous and have yet to be fully exploited.